title: Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?
authors.affiliation: Medikal Onkoloji BD, Acibadem Universitesi Tip Fakültesi Adana Hastanesi, Adana, Turkey. Electronic address: habali1970@yahoo.com.
authors.forename: H
authors.initials: H
authors.lastname: Abali
authors.affiliation: Medikal Onkoloji BD, Acibadem Universitesi Tip Fakültesi Adana Hastanesi, Adana, Turkey.
authors.forename: S
authors.initials: S
authors.lastname: Yavuz
authors.affiliation: Medikal Onkoloji BD, Acibadem Universitesi Tip Fakültesi Adana Hastanesi, Adana, Turkey.
authors.forename: Z
authors.initials: Z
authors.lastname: Calıkusu
authors.affiliation: Medikal Onkoloji BD, Acibadem Universitesi Tip Fakültesi Adana Hastanesi, Adana, Turkey.
authors.forename: E
authors.initials: E
authors.lastname: Seyrek
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D008297:Male; D010094:Oxonic Acid / Q000627:therapeutic use*; D005641:Tegafur / Q000627:therapeutic use*; D014498:Uracil / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D014498:Uracil; D010094:Oxonic Acid; D002955:Leucovorin